Radiomics Based on MR Imaging of Rectal Mucinous Adenocarcinoma: Assess Treatment Response to Neoadjuvant Chemoradiotherapy
Fu Shen1, Minglu Liu1, Zhihui Li1, Xiaolu Ma1, Jianping Lu1, and Yuwei Xia2
1Changhai Hospital, Shanghai, China, 2Huiying Medical Technology Co., Ltd., Beijing, China
We developed a radiomics model
with excellent performance for individualized, noninvasive prediction of
tumor regression in patients with rectal mucinous adenocarcinoma (RMAC).
The ROC curve for LR
classifier